The Smad proteins and TGFβ signalling: Uncovering a pathway critical in cancer

Pathology

Volumn 33, Issue 1, 2001, Pages 73-84

  Rooke, H M ^a   Crosier, K E ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Cancer; Growth inhibition; Signal transduction; Smad; TGF

Indexed keywords

PROTEIN SERINE THREONINE KINASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; DNA BINDING PROTEIN; SMAD2 PROTEIN; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN; SMAD4 PROTEIN; SMAD4 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; CANCER; CANCER GROWTH; CANCER INHIBITION; CANCER RESISTANCE; CARCINOGENESIS; CELL NUCLEUS; CELL SURFACE; GENE MUTATION; HUMAN; NONHUMAN; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; METABOLISM; NEOPLASM; REVIEW;

DNA-BINDING PROTEINS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034745460     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020123383     Document Type: Article

References (102)

1. The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms
2. New class of transforming growth factors potentiated by epidermal growth factor: Isolation from non-neoplastic tissues
3. The transforming growth factor-beta family
4. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice
5. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease
6. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death
7. TGFbeta2 knockout mice have' multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes
8. Transforming growth factor-beta 3 is required for secondary palate fusion
9. Abnormal lung development and cleft palate in mice lacking TGF-heta 3 indicates defects of epithelial-mesenchymal interaction
10. TGF-beta induces himodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop
11. Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation
12. Transforming growth factor β directly regulates primitive murine hematopoietic cell proliferation
13. Mammalian G1 cyclins
14. p151NK4B is a potential effector of TGF-beta-induced cell cycle arrest
15. Kip/Cip and Ink4 Cdk inhihitors cooperate to induce cell cycle arrest in response to TGF-beta
16. CDK inhihitors: Positive and negative regulators of Gl-phase progression
17. TGF-heta-receptor-mediated signaling
18. Reconstitution and transphosphorylation of TGF-beta receptor complexes
19. Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart
20. Endoglin, an ancillary TGFbeta receptor is required for extraembryonic angiogenesis and plays a key role in heart development
21. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1
22. Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin
23. Cell-associated activation of latent transforming growth factor-beta by calpain
24. Genetic characterisation and cloning of Mothers Against dpp, a gene required for decapentaplegic function in Drosophila melanogaster
25. Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components
26. Nomenclature: Vertebrate mediators of TGFβ family signals
27. MADR1, a MAD-related protein that functions in BMP2 signaling pathways
28. A human Mad protein acting as a BMP-regulated transcriptional activator
29. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway
30. The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis
31. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
32. Determinants of specificity in TGF-beta signal transduction
33. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
34. A structural basis for mutational inactivation of the tumour suppressor Smad4
35. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling
36. Smad6 inhibits signalling by the TGF-beta superfamily
37. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling
38. Vascular MADs: Two novel MAD-related genes selectively inducible by flow in human vascular endothelium
39. Daughters against dpp modulates dpp organizing activity in Drosophila wing development
40. Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-beta receptors
41. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members
42. Smad6 inhibits BMP/Smadl signaling by specifically competing with the Smad4 tumor suppressor
43. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway
44. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor
45. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4
46. Crystal structure of a Smad MH1 domain bound to DNA: Insights on DNA binding in TGF-beta signaling
47. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene
48. A transcriptional partner for MAD proteins in TGF-β signalling
49. Smad4 and FAST-1 in the assembly of activin-responsive factor
50. Smad3 and Smad4 cooperate with c-Jur/c-Fos to mediate TGF-beta-induced transcription
51. Smads bind directly to the Jun family of AP-1 transcription factors
52. Opening the way to gene activity
53. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation
54. TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300
55. Physical and functional interaction of SMADs and p300/CBP
56. A Smad transcriptional corepressor
57. The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling
58. Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein
59. Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling
60. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling
61. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction
62. Organization and regulation of mitogen-activated protein kinase signaling pathways
63. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling
64. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway
65. Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12
66. The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type 1 receptors
67. Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12
68. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smadl
69. A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras
70. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators
71. Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins
72. MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells
73. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability
74. A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability
75. Genetic instability and mutation of the TGF-beta-receptor-II gene in ampullary carcinomas
76. Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas
77. Mutator phenotype in a subset of chronic lymphocytic leukemia
78. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers
79. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer
80. Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells
81. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma
82. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer
83. Smad4 (DPC4)-a potent tumour suppressor?
84. Frequency of Smad gene mutations in human cancers
85. Somatic alterations of the SMAD-2 gene in human colorectal cancers
86. Smad3 mutant mice develop metastatic colorectal cancer
87. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas
88. The t(3;21) fusion product, AML/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells
89. Genetic events and the role of TGF beta in epithelial tumour progression
90. The TGF-beta type II receptor in chronic myeloid leukemia: Analysis of microsatellite regions and gene expression
91. Reduced surface expression of transforming growth factor receptor β type II in mitogen-activated T cells from Sézary patients
92. Loss of receptors for transforming growth factor [3 in human T-cell malignancies
93. Down-regulation of TGF-beta receptors in human colorectal cancer: Implications for cancer development
94. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis
95. Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer
96. Cyclosporine induces cancer progression by a cell-autonomous mechanism
97. Expression of transforming growth factor-beta 1 in prostate cancer
98. Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells
99. Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines
100. DPC4 gene in various tumor types
101. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers
102. Deletion and altered regulation of p l6INK4a and p15INK4b in undifferentiated mouse skin tumors